Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Argus Health
AstraZeneca
Deloitte
Fuji
Merck
Colorcon
Farmers Insurance

Generated: April 21, 2018

DrugPatentWatch Database Preview

SULFAMYLON Drug Profile

« Back to Dashboard

When do Sulfamylon patents expire, and when can generic versions of Sulfamylon launch?

Sulfamylon is a drug marketed by Mylan Institutional and is included in two NDAs.

The generic ingredient in SULFAMYLON is mafenide acetate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.
Drug patent expirations by year for SULFAMYLON
Pharmacology for SULFAMYLON
Medical Subject Heading (MeSH) Categories for SULFAMYLON
Synonyms for SULFAMYLON
13009-99-9
4-(aminomethyl)-benzenesulfonamidmonoacetate
4-(aminomethyl)benzene-1-sulfonamide; acetic acid
4-(AMINOMETHYL)BENZENESULFONAMIDE ACETATE
4-(Aminomethyl)benzenesulfonamide monoacetate
4-(aminomethyl)benzenesulfonamide, acetic acid
4-(aminomethyl)benzenesulfonamidemonoacetate
4-Aminomethylbenzenesulfonamide acetate salt
4CH-007432
AB0015310
AC-22835
AC1L19D6
acetic acid; 4-(aminomethyl)benzenesulfonamide
acetic acid; emilene
acetic acid;4-(aminomethyl)benzenesulfonamide
AK-33093
AKOS000121908
alpha-Amino-p-toluenesulfonamide monoacetate
alpha-amino-p-toluenesulfonamidmonoacetate
alpha-Aminotoluene-4-sulphonamide monoacetate
AM20050421
ANW-50131
ARONIS24094
AT-3012
BB_SC-5642
Benzenesulfonamide, 4-(aminomethyl)-, monoacetate
C7H10N2O2S
CHEBI:31792
CHEMBL1201161
CPD000058778
CS-2839
CTK8B5794
D01166
DR000623
DS-2178
DTXSID00156334
EBD47349
EINECS 235-855-0
FT-0630395
HMS2231M06
HMS3259N08
HMS3370M14
HY-B0614A
KB-238734
KS-00000GIF
KS-000046K4
LS-154099
M626
Mafatate
Mafenamide acetate
Mafenide (Acetate)
MAFENIDE ACETATE
Mafenide acetate (JAN/USP)
Mafenide acetate [USAN:JAN]
Mafenide acetate [USP:JAN]
Mafenide acetate, United States Pharmacopeia (USP) Reference Standard
Maphenide acetate
maphenideacetate
marfanil acetate salt
MFCD00072089
MLS000069581
MolPort-004-288-407
MP-0204
NC00709
p-Aminomethylbenzenesulfonamide acetate
p-Toluenesulfonamide, alpha-amino-, monoacetate
RQ6LP6Z0WY
SAM002589996
SBB080601
SC-17842
SCHEMBL41627
SMR000058778
ST24028787
ST45053309
Sulfamilon
Sulfamylon (TN)
TR-004108
TRA0071755
UILOTUUZKGTYFQ-UHFFFAOYSA-N
UNII-RQ6LP6Z0WY
W-108356
Winthrocine

US Patents and Regulatory Information for SULFAMYLON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional SULFAMYLON mafenide acetate CREAM;TOPICAL 016763-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional SULFAMYLON mafenide acetate FOR SOLUTION;TOPICAL 019832-003 Jun 5, 1998 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fish and Richardson
Argus Health
Mallinckrodt
US Department of Justice
Citi
Harvard Business School
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.